Immunovant, Inc. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2025-01-21. The offering totals $450.0M, of which $450.0M was reported sold. Industry: Pharmaceuticals.
| Name | Role | Location |
|---|---|---|
| Andrew Fromkin | Director | New York, NY |
| Douglas Hughes | Director | Pleasanton, CA |
| George Migausky | Director | New York, NY |
| Atul Pande | Director | New York, NY |
| Pete Salzmann | Director | New York, NY |
| Frank Torti | Director | New York, NY |
| Eric Venker | Director | New York, NY |
| Eva Renee Barnett | Executive Officer | New York, NY |
| Michael Geffner | Executive Officer | New York, NY |
| Melanie Gloria | Executive Officer | New York, NY |
| Bill Macias | Executive Officer | New York, NY |
| Pete Salzmann | Executive Officer | New York, NY |
| Jay Stout | Executive Officer | New York, NY |
| Christopher Van Tuyl | Executive Officer | New York, NY |